<Anchor> The



AstraZeneca vaccine, which is being vaccinated in Korea, is being commissioned by a domestic company called SK Bioscience.

Ahead of the listing of the KOSPI next week, this company started accepting subscriptions for public offerings today (9th).

Expectations are high for vaccine-related weeks, and as the subscription method changed from this year was applied, more than 14 trillion won was collected on the first day alone.



Reporter Lim Tae-woo reported.



<Reporter>



It is crowded with customers waiting for their turn to apply at a brokerage branch.



Even after pulling out a waiting ticket, they may wait for more than an hour.



[General Subscription Investor: When I read the newspaper this morning, it was a prospect, and it was introduced like that.

So I tried it.] The



first day of subscription to SK Bioscience.



As investors continued to visit, 14 trillion won was collected as margin on the first day of the subscription.



This is more than SK Biopharm and Big Hit Entertainment, which caused the subscription craze last year.



On the first day, the competition rate reached 76:1.



From this year on, the more margins you pay, the more shares you receive, but from this year onwards, half the amount allocated to public offerings is distributed equally regardless of the size of the margin, and it is also possible to create multiple accounts and subscribe more than once, attracting more investors. .



[Kim Dong-woon/Head of NH Investment & Securities Center: Not only minors, but also fathers, mothers, grandchildren, etc. There are quite a lot of family openings, so if you do business with one person (guests), you can open an account for up to an hour...

.]



Stock prices are even predicting the possibility of hitting the upper limit after the initial price on the day of listing has doubled the public offering price when looking at the company's prospects and open subscription.



They are expecting very high returns, but experts advise that you should be prepared for large volatility given the recent contraction of stock market conditions and profit-taking offerings.



(Video coverage: Oh Young-chun, video editing: Lee Seung-yeol)